 |
PDBsum entry 1dfv
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Sugar binding protein
|
PDB id
|
|
|
|
1dfv
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
39:1935-1941
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin.
|
|
D.H.Goetz,
S.T.Willie,
R.S.Armen,
T.Bratt,
N.Borregaard,
R.K.Strong.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Neutrophil gelatinase associated lipocalin (NGAL), a constituent of neutrophil
granules, is a member of the lipocalin family of binding proteins. NGAL can also
be highly induced in epithelial cells in both inflammatory and neoplastic
colorectal disease. NGAL is proposed to mediate inflammatory responses by
sequestering neutrophil chemoattractants, particularly N-formylated tripeptides
and possibly leukotriene B(4) and platelet activating factor. The crystal
structures of NGAL display a typical lipocalin fold, albeit with an unusually
large and atypically polar binding site, or calyx. The fold of NGAL is most
similar to the epididymal retinoic acid-binding protein, another lipocalin,
though the overall architecture of the calyces are very different. The crystal
structures also reveal either sulfate ions or an adventitiously copurified fatty
acid bound in the binding site. Neither ligand is displaced by added
N-formylated tripeptides. The size, shape, and character of the NGAL calyx, as
well as the low relative affinity for N-formylated tripeptides, suggest that
neither the copurified fatty acid nor any of the proposed ligands are likely to
be the preferred ligand of this protein. Comparisons between the crystal
structures and the recently reported solution structure of NGAL reveal
significant differences, in terms of both the details of the structure and the
overall flexibility of the fold.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.T.Tsai,
P.H.Su,
T.H.Lee,
Y.T.Tee,
L.Y.Lin,
S.F.Yang,
and
P.H.Wang
(2011).
Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease.
|
| |
Clin Chim Acta,
412,
1252-1256.
|
 |
|
|
|
|
 |
G.Bao,
M.Clifton,
T.M.Hoette,
K.Mori,
S.X.Deng,
A.Qiu,
M.Viltard,
D.Williams,
N.Paragas,
T.Leete,
R.Kulkarni,
X.Li,
B.Lee,
A.Kalandadze,
A.J.Ratner,
J.C.Pizarro,
K.M.Schmidt-Ott,
D.W.Landry,
K.N.Raymond,
R.K.Strong,
and
J.Barasch
(2010).
Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex.
|
| |
Nat Chem Biol,
6,
602-609.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.M.Moreno-Navarrete,
M.Manco,
J.Ibáñez,
E.García-Fuentes,
F.Ortega,
E.Gorostiaga,
J.Vendrell,
M.Izquierdo,
C.Martínez,
G.Nolfe,
W.Ricart,
G.Mingrone,
F.Tinahones,
and
J.M.Fernández-Real
(2010).
Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance.
|
| |
Int J Obes (Lond),
34,
240-249.
|
 |
|
|
|
|
 |
D.A.Breustedt,
L.Chatwell,
and
A.Skerra
(2009).
A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity.
|
| |
Acta Crystallogr D Biol Crystallogr,
65,
1118-1125.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.J.Woo,
J.C.Park,
C.H.Bae,
S.Y.Song,
H.M.Lee,
and
Y.D.Kim
(2009).
Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
|
| |
Acta Otolaryngol,
129,
624-629.
|
 |
|
|
|
|
 |
M.C.Clifton,
C.Corrent,
and
R.K.Strong
(2009).
Siderocalins: siderophore-binding proteins of the innate immune system.
|
| |
Biometals,
22,
557-564.
|
 |
|
|
|
|
 |
M.Sandy,
and
A.Butler
(2009).
Microbial iron acquisition: marine and terrestrial siderophores.
|
| |
Chem Rev,
109,
4580-4595.
|
 |
|
|
|
|
 |
Y.R.Chan,
J.S.Liu,
D.A.Pociask,
M.Zheng,
T.A.Mietzner,
T.Berger,
T.W.Mak,
M.C.Clifton,
R.K.Strong,
P.Ray,
and
J.K.Kolls
(2009).
Lipocalin 2 is required for pulmonary host defense against Klebsiella infection.
|
| |
J Immunol,
182,
4947-4956.
|
 |
|
|
|
|
 |
D.Bolignano,
V.Donato,
G.Coppolino,
S.Campo,
A.Buemi,
A.Lacquaniti,
and
M.Buemi
(2008).
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.
|
| |
Am J Kidney Dis,
52,
595-605.
|
 |
|
|
|
|
 |
F.Wei,
A.Karihaloo,
Z.Yu,
A.Marlier,
P.Seth,
S.Shibazaki,
T.Wang,
V.P.Sukhatme,
S.Somlo,
and
L.G.Cantley
(2008).
Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo.
|
| |
Kidney Int,
74,
1310-1318.
|
 |
|
|
|
|
 |
J.H.Lee,
K.C.Kye,
E.Y.Seo,
K.Lee,
S.K.Lee,
J.S.Lim,
Y.J.Seo,
C.D.Kim,
and
J.K.Park
(2008).
Expression of neutrophil gelatinase-associated lipocalin in calcium-induced keratinocyte differentiation.
|
| |
J Korean Med Sci,
23,
302-306.
|
 |
|
|
|
|
 |
F.Aigner,
H.T.Maier,
H.G.Schwelberger,
E.A.Wallnöfer,
A.Amberger,
P.Obrist,
T.Berger,
T.W.Mak,
M.Maglione,
R.Margreiter,
S.Schneeberger,
and
J.Troppmair
(2007).
Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart.
|
| |
Am J Transplant,
7,
779-788.
|
 |
|
|
|
|
 |
M.A.Fischbach,
H.Lin,
L.Zhou,
Y.Yu,
R.J.Abergel,
D.R.Liu,
K.N.Raymond,
B.L.Wanner,
R.K.Strong,
C.T.Walsh,
A.Aderem,
and
K.D.Smith
(2006).
The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2.
|
| |
Proc Natl Acad Sci U S A,
103,
16502-16507.
|
 |
|
|
|
|
 |
N.Borregaard,
and
J.B.Cowland
(2006).
Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein.
|
| |
Biometals,
19,
211-215.
|
 |
|
|
|
|
 |
R.J.Playford,
A.Belo,
R.Poulsom,
A.J.Fitzgerald,
K.Harris,
I.Pawluczyk,
J.Ryon,
T.Darby,
M.Nilsen-Hamilton,
S.Ghosh,
and
T.Marchbank
(2006).
Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair.
|
| |
Gastroenterology,
131,
809-817.
|
 |
|
|
|
|
 |
D.A.Breustedt,
I.P.Korndörfer,
B.Redl,
and
A.Skerra
(2005).
The 1.8-A crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands.
|
| |
J Biol Chem,
280,
484-493.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.A.Gwira,
F.Wei,
S.Ishibe,
J.M.Ueland,
J.Barasch,
and
L.G.Cantley
(2005).
Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro.
|
| |
J Biol Chem,
280,
7875-7882.
|
 |
|
|
|
|
 |
M.A.Holmes,
W.Paulsene,
X.Jide,
C.Ratledge,
and
R.K.Strong
(2005).
Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration.
|
| |
Structure,
13,
29-41.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.K.Krishna
(2005).
Identification of structural domains involved in astrovirus capsid biology.
|
| |
Viral Immunol,
18,
17-26.
|
 |
|
|
|
|
 |
S.Schlehuber,
and
A.Skerra
(2005).
Anticalins as an alternative to antibody technology.
|
| |
Expert Opin Biol Ther,
5,
1453-1462.
|
 |
|
|
|
|
 |
C.E.Doneanu,
R.K.Strong,
and
W.N.Howald
(2004).
Characterization of a noncovalent lipocalin complex by liquid chromatography/electrospray ionization mass spectrometry.
|
| |
J Biomol Tech,
15,
208-212.
|
 |
|
|
|
|
 |
H.Oku,
T.Ohyama,
A.Hiroki,
K.Yamada,
K.Fukuyama,
H.Kawaguchi,
and
R.Katakai
(2004).
Addition of a peptide fragment on an alpha-helical depsipeptide induces alpha/3(10)-conjugated helix: synthesis, crystal structure, and CD spectra of Boc-Leu-Leu-Ala-(Leu-Leu-Lac)3-Leu-Leu-OEt.
|
| |
Biopolymers,
75,
242-254.
|
 |
|
|
|
|
 |
K.N.Raymond,
E.A.Dertz,
and
S.S.Kim
(2003).
Enterobactin: an archetype for microbial iron transport.
|
| |
Proc Natl Acad Sci U S A,
100,
3584-3588.
|
 |
|
|
|
|
 |
D.H.Goetz,
M.A.Holmes,
N.Borregaard,
M.E.Bluhm,
K.N.Raymond,
and
R.K.Strong
(2002).
The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.
|
| |
Mol Cell,
10,
1033-1043.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Mallbris,
K.P.O'Brien,
A.Hulthén,
B.Sandstedt,
J.B.Cowland,
N.Borregaard,
and
M.Ståhle-Bäckdahl
(2002).
Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin.
|
| |
Exp Dermatol,
11,
584-591.
|
 |
|
|
|
|
 |
H.Tschesche,
V.Zölzer,
S.Triebel,
and
S.Bartsch
(2001).
The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases.
|
| |
Eur J Biochem,
268,
1918-1928.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |